-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點摘要如下:ASML公佈2026年第一季銷售額為87.7億歐元(年成長13%),高於市場預期的86.8億歐元;每股收益為7.15歐元(年成長19%),較市場預期的6.62歐元高出8%。毛利率為53.0%,達到先前預期(51%-53%)的高端,這主要得益於高利潤率的現有客戶群業務表現超出預期,而強勁的升級活動(預計這一趨勢將持續)可能對此有所好處。記憶體業務貢獻了淨系統銷售額的51%(第四季為30%),這主要得益於人工智慧需求、持續的記憶體短缺以及EUV光刻技術滲透率的提高,市場需求持續走強。儘管有許多不確定性,但由於非EUV光刻業務前景改善,公司將2026年營收預期從365億歐元上調至約380億歐元(成長16.3%)。管理階層預計,到2026年,EUV光刻產能將擴展至60套以上低數值孔徑(Low NA)系統(2025年約為50套),到2027年將擴展至80套以上。我們認為,這將為公司提供價格/產能提升之外的另一個重要成長動力,而價格/產能提升正是2025年業績成長的主要驅動力。中國市場佔比顯著下降至第一季銷售額的19%(第四季為36%),而韓國市場佔比則飆升至45%(第四季為22%),反映出記憶體製造商的需求正在加速成長。
Related Articles
Hongqiao Aluminum's Profit Jumps 38%, Revenue Up 3%
Shandong Hongqiao Aluminum Industry (SHE:002379) reported a 38% jump in attributable net profit in the first quarter of 2026 to 6.76 billion yuan from 4.91 billion yuan, according to a filing on the Shenzhen Stock Exchange over the weekend.Diluted earnings per share rose to 0.5186 yuan from 0.3770 yuan.The aluminum company's revenue edged up 3.21% to 40.9 billion yuan from 39.7 billion yuan.
Cofoe Medical Technology Seeks Up to HK$1.06 Billion in Hong Kong IPO
Cofoe Medical Technology (HKG:1187, SHE:301087) launched its Hong Kong initial public offering on Monday, seeking to raise up to about HK$1.06 billion from the deal.The China-based home care medical device provider is offering 27 million H-shares at a maximum offer price of HK$39.33 per share, according to a Hong Kong bourse filing.The offering comprises 2.7 million shares for Hong Kong investors and 24.3 million shares for international investors, subject to reallocation.The offer price is expected to be determined by May 4, with allocation results due by May 5, ahead of the company's planned trading debut on May 6.Net proceeds will be used mainly to support global expansion and strengthen overseas sales channels, as well as advance product research and development.The funds will also be used to expand domestic distribution networks, enhance branding and marketing efforts, and for working capital and general corporate purposes.Huatai Financial Holdings (Hong Kong) and BNP Paribas Securities (Asia) are acting as joint sponsors.Huatai Financial Holdings (Hong Kong) and BNP Paribas Securities (Asia) are serving as overall coordinators and are also acting as joint bookrunners and joint lead managers, alongside Futu Securities International (Hong Kong).
CMOC Group's Q1 Profit Nearly Doubles as Revenue Jumps 44%
CMOC Group (SHA:603993, HKG:3993) reported a 97% jump in attributable net profit in the first quarter of 2026 to 7.76 billion yuan from 3.95 billion yuan a year ago, according to filings on the Shanghai and Hong Kong bourses over the weekend.Diluted earnings per share doubled to 0.36 yuan from 0.18 yuan.The copper and cobalt producer's revenue edged up 44% to 66.4 billion yuan from 46 billion yuan.